New drug combo trial offers hope for advanced stomach, colon & pancreatic cancers
NCT ID NCT07233850
Summary
This study is testing whether adding an experimental drug called SSGJ-706 to standard first-line chemotherapy is safe and more effective for treating advanced cancers of the digestive system. It will enroll 300 adults with advanced stomach, colorectal, pancreatic, or esophageal cancer who have not yet received treatment for their metastatic disease. The main goals are to see if the combination causes manageable side effects and if it helps shrink tumors better than standard treatment alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER (CRC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430030, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.